Spironolactone 5% Shows Significant Results in Acne Treatment: Meta-Analysis

A recent meta-analysis published in the Archives of Dermatological Research highlights the effectiveness and safety of 5% spironolactone for treating acne. This systematic review analyzed 14 studies involving 1,086 participants and found that spironolactone significantly reduces acne severity and lesion count while maintaining an excellent safety profile.

Acne vulgaris affects around 9% of the global population, with a higher prevalence in women, often impacting their self-esteem and quality of life. While mild acne is commonly treated with topical therapies, systemic treatments are necessary for managing moderate to severe cases. Spironolactone, an androgen receptor inhibitor, is emerging as a promising treatment option for persistent acne.

Key Findings from the Meta-Analysis

5% Spironolactone significantly reduced the total acne lesion count (MD −6.85) and Acne Severity Index (ASI) (MD −6.33) compared to placebo.
100 mg oral spironolactone showed greater improvement in acne severity compared to topical treatments.
While improvements in comedones and pustules were modest within the first 6–8 weeks, notable results appeared after eight weeks of treatment.
The drug demonstrated an excellent safety profile with minimal side effects.

Why Spironolactone Matters in Acne Treatment

Spironolactone works by blocking androgen receptors, which reduces oil production and inflammation in the skin—both major factors in acne development. It is particularly effective for hormonal or persistent acne in women.

What Does This Mean for Clinicians?

The findings suggest that spironolactone could become a widely accepted treatment for patients struggling with moderate to severe acne, especially those who do not respond well to traditional treatments. However, experts recommend further large-scale studies to confirm its long-term efficacy and determine the best dosage.

For healthcare providers treating patients with persistent acne, it’s time to explore the potential of spironolactone as part of your treatment options. Stay informed on the latest research and provide your patients with safe, effective solutions. Contact us today to learn more about emerging acne therapies and how they can improve patient outcomes.

To register for our next masterclass please click here https://linktr.ee/docpreneur